Instituto de Salud Carlos III (ISCIII)
Supporter
The Instituto de Salud Carlos III (ISCIII) is the main public research entity funding, managing and carrying out biomedical research in Spain. It is also the body responsible for managing the Health Research and Development Strategy within the framework of the National Plan of R&D.
Membership discount for your BMC & SpringerOpen article processing charges (APCs)
As an affiliated author, a membership discount is available on your APC.
Please follow the submission guidelines to benefit from this membership discount.
Instituto de Salud Carlos III (ISCIII)'s Articles
Page 3 of 23
-
Citation: BMC Psychiatry 2024 24:24
-
A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts
Citation: Molecular Medicine 2024 30:3 -
Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases
Citation: Respiratory Research 2023 24:320 -
Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk
Citation: Immunity & Ageing 2023 20:62 -
Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves
Citation: Cardiovascular Diabetology 2023 22:314 -
Circulating miRNAs signature on breast cancer: the MCC-Spain project
Citation: European Journal of Medical Research 2023 28:480 -
Effectiveness of a scalable, remotely delivered stepped-care intervention to reduce symptoms of psychological distress among Polish migrant workers in the Netherlands: study protocol for the RESPOND randomised controlled trial
Citation: BMC Psychiatry 2023 23:801 -
Autism spectrum disorder prevalence in Italy: a nationwide study promoted by the Ministry of Health
Citation: Child and Adolescent Psychiatry and Mental Health 2023 17:125 -
Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort
Citation: BMC Medicine 2023 21:390 -
Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach
Citation: Human Genomics 2023 17:85 -
Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance
Citation: Virology Journal 2023 20:153 -
Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia
Citation: Cardiovascular Diabetology 2023 22:179 -
Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern Spain
Citation: Parasites & Vectors 2023 16:195 -
Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
Citation: Cell Communication and Signaling 2023 21:89 -
Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Citation: Acta Neuropathologica Communications 2023 11:55 -
Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study
Citation: BMC Medicine 2023 21:82 -
Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study
Citation: Journal of Foot and Ankle Research 2023 16:8 -
Diagnostic pathways of Chagas disease in Spain: a qualitative study
Citation: BMC Public Health 2023 23:332 -
Staphylococcus aureus populations from the gut and the blood are not distinguished by virulence traits—a critical role of host barrier integrity
Citation: Microbiome 2022 10:239 -
Molecular detection of Ehrlichia spp. in ticks parasitizing wild lagomorphs from Spain: characterization of a novel Ehrlichia species
Citation: Parasites & Vectors 2022 15:467